Esparza-López José, Ramos-Elías Pier A, Castro-Sánchez Andrea, Rocha-Zavaleta Leticia, Escobar-Arriaga Elizabeth, Zentella-Dehesa Alejandro, León-Rodríguez Eucario, Medina-Franco Heriberto, Ibarra-Sánchez María de Jesus
Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Vasco de Quiroga 15, Belisario Domínguez Sección XVI, Delegación Tlalpan, CP 14080, Distrito Federal, Mexico.
Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Circuito Escolar S/N, Ciudad Universitaria, Delegación Coyoacán, CP 04500, Distrito Federal, Mexico.
BMC Cancer. 2016 Sep 20;16(1):740. doi: 10.1186/s12885-016-2769-0.
It has become evident that intra-tumor heterogeneity of breast cancer impact on several biological processes such as proliferation, migration, cell death and also might contribute to chemotherapy resistance. The expression of Receptor Tyrosine Kinases (RTKs) has not been analyzed in the context of intra-tumor heterogeneity in a primary breast cancer cell culture. Several subpopulations were isolated from the MBCDF (M serial-breast cancer ductal F line) primary breast cancer cells and were successfully maintained in culture and divided in two groups according to their morphology and RTKs expression pattern, and correlated with biological processes like proliferation, migration, anchorage-independent cell growth, and resistance to cytotoxic chemotherapy drugs and tyrosine kinase inhibitors (TKIs).
Subpopulations were isolated from MBCDF primary breast cancer cell culture by limiting dilution. RTKs and hormone receptors were examined by Western blot. Proliferation was measure by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT assay). Cell viability was evaluated by Crystal Violet. Migration was assessed using Boyden chambers. Anchorage-independent cell growth was evaluated by colony formation in soft agar.
Several subpopulations were isolated from the MBCDF breast cancer cells that were divided into two groups according to their morphology. Analysis of RTKs expression pattern showed that HER1, HER3, c-Met and VEGFR2 were expressed exclusively in cells from group 1, but not in cells from group 2. PDGFR was expressed only in cells from group 2, but not in cells from group 1. HER2, HER4, c-Kit, IGF1-R were expressed in all subpopulations. Biological processes correlated with the RTKs expression pattern. Group 2 subpopulations present the highest rate of cell proliferation, migration and anchorage-independent cell growth. Analysis of susceptibility to chemotherapy drugs and TKIs showed that only Paclitaxel and Imatinib behaved differently between groups. Group 1-cells were resistant to both Paclitaxel and Imatinib.
We demonstrated that subpopulations from MBCDF primary cell culture could be divided into two groups according to their morphology and a RTKs excluding-expression pattern. The differences observed in RTKs expression correlate with the biological characteristics and chemoresistance of each group. These results suggest that intra-tumor heterogeneity contributes to generate groups of subpopulations with a more aggressive phenotype within the tumor.
乳腺癌的肿瘤内异质性对增殖、迁移、细胞死亡等多种生物学过程产生影响,还可能导致化疗耐药。在原发性乳腺癌细胞培养中,尚未在肿瘤内异质性背景下分析受体酪氨酸激酶(RTKs)的表达情况。从MBCDF(M系列乳腺癌导管F系)原发性乳腺癌细胞中分离出多个亚群,并成功在培养中维持,根据其形态和RTKs表达模式分为两组,并与增殖、迁移、非锚定依赖性细胞生长以及对细胞毒性化疗药物和酪氨酸激酶抑制剂(TKIs)的耐药性等生物学过程相关联。
通过有限稀释从MBCDF原发性乳腺癌细胞培养物中分离亚群。通过蛋白质免疫印迹法检测RTKs和激素受体。用3 - [4,5 - 二甲基噻唑 - 2 - 基] - 2,5 - 二苯基溴化四氮唑(MTT法)测量增殖。用结晶紫评估细胞活力。使用博伊登小室评估迁移。通过软琼脂中的集落形成评估非锚定依赖性细胞生长。
从MBCDF乳腺癌细胞中分离出多个亚群,根据其形态分为两组。RTKs表达模式分析表明,HER1、HER3、c - Met和VEGFR2仅在第1组细胞中表达,而不在第2组细胞中表达。PDGFR仅在第2组细胞中表达,而不在第1组细胞中表达。HER2、HER4、c - Kit、IGF1 - R在所有亚群中均有表达。生物学过程与RTKs表达模式相关。第2组亚群呈现出最高的细胞增殖、迁移和非锚定依赖性细胞生长速率。化疗药物和TKIs敏感性分析表明,只有紫杉醇和伊马替尼在两组之间表现不同。第1组细胞对紫杉醇和伊马替尼均耐药。
我们证明,来自MBCDF原代细胞培养的亚群可根据其形态和RTKs排除表达模式分为两组。RTKs表达中观察到的差异与每组的生物学特征和化疗耐药性相关。这些结果表明,肿瘤内异质性有助于在肿瘤内产生具有更具侵袭性表型的亚群组。